Nefropatías secundarias a paraproteína: perfil clínico a partir de hallazgos histológicos

Background: One of the devastating consequences of monoclonal gammopathies is the development of end-stage kidney disease, which can be prevented with an early diagnosis. Renal involvement can be secondary to saturation of paraproteins with intratubular precipitation or the glomerular deposition of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jerez,Joaquín, Juanet,Cristián, Sharp,Joaquín, Ernst,Daniel, Méndez,Gonzalo P., Sepúlveda,Rodrigo A.
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2020
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872020000801059
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872020000801059
record_format dspace
spelling oai:scielo:S0034-988720200008010592020-12-26Nefropatías secundarias a paraproteína: perfil clínico a partir de hallazgos histológicosJerez,JoaquínJuanet,CristiánSharp,JoaquínErnst,DanielMéndez,Gonzalo P.Sepúlveda,Rodrigo A. Glomerulonephritis Multiple Myeloma Nephrotic Syndrome Paraproteinemias Proteinuria Background: One of the devastating consequences of monoclonal gammopathies is the development of end-stage kidney disease, which can be prevented with an early diagnosis. Renal involvement can be secondary to saturation of paraproteins with intratubular precipitation or the glomerular deposition of paraproteins with secondary inflammation and destruction. These conditions can also be associated with monoclonal gammopathies that do not meet hematological treatment criteria, called monoclonal gammopathies of renal significance (MGRS). Aim: To report a retrospective analysis of patients who underwent a renal biopsy and whose final diagnosis was a form of monoclonal gammopathy. Material and Methods: We reviewed the clinical and laboratory features and response to treatment of 22 patients aged 63 ± 12 years (55% women) with a pathological diagnosis of a nephropathy associated with paraproteinemia. Results: The most common hematological diagnosis was amyloidosis in 50% of patients, followed by cast nephropathy. The predominant clinical presentations were proteinuria (without nephrotic syndrome) and nephritic syndrome. Classic criteria such as erythrocyte sedimentation rate > 100 mm/h and protein-albumin gap were unusual. Serum light chain quantification was the test with the best yield to detect paraproteins. Conclusions: In this group of patients, light chains tend to affect the kidney more commonly than heavy chains. The prognosis of multiple myeloma is much worse than MGRS.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.148 n.8 20202020-08-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872020000801059es10.4067/S0034-98872020000801059
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Glomerulonephritis
Multiple Myeloma
Nephrotic Syndrome
Paraproteinemias
Proteinuria
spellingShingle Glomerulonephritis
Multiple Myeloma
Nephrotic Syndrome
Paraproteinemias
Proteinuria
Jerez,Joaquín
Juanet,Cristián
Sharp,Joaquín
Ernst,Daniel
Méndez,Gonzalo P.
Sepúlveda,Rodrigo A.
Nefropatías secundarias a paraproteína: perfil clínico a partir de hallazgos histológicos
description Background: One of the devastating consequences of monoclonal gammopathies is the development of end-stage kidney disease, which can be prevented with an early diagnosis. Renal involvement can be secondary to saturation of paraproteins with intratubular precipitation or the glomerular deposition of paraproteins with secondary inflammation and destruction. These conditions can also be associated with monoclonal gammopathies that do not meet hematological treatment criteria, called monoclonal gammopathies of renal significance (MGRS). Aim: To report a retrospective analysis of patients who underwent a renal biopsy and whose final diagnosis was a form of monoclonal gammopathy. Material and Methods: We reviewed the clinical and laboratory features and response to treatment of 22 patients aged 63 ± 12 years (55% women) with a pathological diagnosis of a nephropathy associated with paraproteinemia. Results: The most common hematological diagnosis was amyloidosis in 50% of patients, followed by cast nephropathy. The predominant clinical presentations were proteinuria (without nephrotic syndrome) and nephritic syndrome. Classic criteria such as erythrocyte sedimentation rate > 100 mm/h and protein-albumin gap were unusual. Serum light chain quantification was the test with the best yield to detect paraproteins. Conclusions: In this group of patients, light chains tend to affect the kidney more commonly than heavy chains. The prognosis of multiple myeloma is much worse than MGRS.
author Jerez,Joaquín
Juanet,Cristián
Sharp,Joaquín
Ernst,Daniel
Méndez,Gonzalo P.
Sepúlveda,Rodrigo A.
author_facet Jerez,Joaquín
Juanet,Cristián
Sharp,Joaquín
Ernst,Daniel
Méndez,Gonzalo P.
Sepúlveda,Rodrigo A.
author_sort Jerez,Joaquín
title Nefropatías secundarias a paraproteína: perfil clínico a partir de hallazgos histológicos
title_short Nefropatías secundarias a paraproteína: perfil clínico a partir de hallazgos histológicos
title_full Nefropatías secundarias a paraproteína: perfil clínico a partir de hallazgos histológicos
title_fullStr Nefropatías secundarias a paraproteína: perfil clínico a partir de hallazgos histológicos
title_full_unstemmed Nefropatías secundarias a paraproteína: perfil clínico a partir de hallazgos histológicos
title_sort nefropatías secundarias a paraproteína: perfil clínico a partir de hallazgos histológicos
publisher Sociedad Médica de Santiago
publishDate 2020
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872020000801059
work_keys_str_mv AT jerezjoaquin nefropatiassecundariasaparaproteinaperfilclinicoapartirdehallazgoshistologicos
AT juanetcristian nefropatiassecundariasaparaproteinaperfilclinicoapartirdehallazgoshistologicos
AT sharpjoaquin nefropatiassecundariasaparaproteinaperfilclinicoapartirdehallazgoshistologicos
AT ernstdaniel nefropatiassecundariasaparaproteinaperfilclinicoapartirdehallazgoshistologicos
AT mendezgonzalop nefropatiassecundariasaparaproteinaperfilclinicoapartirdehallazgoshistologicos
AT sepulvedarodrigoa nefropatiassecundariasaparaproteinaperfilclinicoapartirdehallazgoshistologicos
_version_ 1718437143637917696